In this episode, Jewel Mullen, MD, MPH, MPA, FACP, discusses strategies for implementing RSV vaccines into practice, with an emphasis on:

• Understanding the reasoning for Advisory Committee on Immunization Practices RSV vaccine recommendations 
• Factors that influence vaccine uptake and patient decision-making
• Considerations for patient and healthcare professional vaccine hesitancy 
• Building vaccine confidence in both patients and healthcare professionals
• Using shared decision-making models (eg, SHARE approach)

Faculty:

Jewel Mullen, MD, MPH, MPA, FACP
Associate Dean for Health Equity
Associate Professor of Population Health and Internal Medicine
University of Texas at Austin Dell Medical School
Austin, Texas

Content based on a CME program supported by an educational grant from GlaxoSmithKline.

Follow along with a downloadable slideset at:
https://bit.ly/44vCnFu

Link to full program:
https://bit.ly/3WvSY9Z

To get access to all of our new podcasts, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Angela Branche, MD, FIDSA, explores the burden of RSV disease in older adults, including:

• RSV seasonality and disease burden
• Symptoms and complications of RSV infection
• Older age as a key risk factor for severe RSV disease and complications (eg, pneumonia, hospitalization)
• Comorbidities associated with increased risk of RSV hospitalization
• RSV hospitalization rates among different racial and ethnic minority groups and socioeconomic statuses 

Faculty:
Angela Branche, MD, FIDSA
Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of Rochester
Rochester, New York

Content based on a CME program supported by an educational grant from GlaxoSmithKline.

Follow along with a downloadable slideset at: 
https://bit.ly/44vCnFu

Link to full program: 
https://bit.ly/3WvSY9Z

To get access to all of our new podcasts, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify

Using common case scenarios, Robert H. Hopkins, Jr., MD, MACP, and Laura P. Hurley, MD, MPH, discuss strategies for optimizing shingles vaccine uptake, including:

• The pathophysiology of shingles to better understand risk and burden
• CDC guidelines and ACIP shingles vaccine recommendations, including considerations for those who are immunocompromised 
• Strategies for optimizing shingles vaccine uptake no matter the clinical setting
• How to address shingles vaccine‒related adverse events 
• Addressing insurance-related concerns 

Presenters:

Robert H. Hopkins, Jr., MD, MACP
Professor of Internal Medicine and Pediatrics
Chief, Division of General Internal Medicine
University of Arkansas for Medical Sciences
School of Medicine
Little Rock, Arkansas

Laura P. Hurley, MD, MPH
General Internist and Health Services Researcher
Associate Professor of Medicine
Department of General Internal Medicine
University of Colorado Anschutz Medical Campus
Aurora, Colorado

Link to downloadable slides:
https://bit.ly/4aWn6jh

Link to full program:
https://bit.ly/4aWBiJ0

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Samantha Strong, PharmD, BCACP, AAHIVP, CDCES, and Nimish Patel, PharmD, PhD, AAHIVP, cover the most impactful clinical studies presented at CROI 2024, including:

• New data on long-acting ART, including:
  • The CARES study of LA CAB + RPV in a sub-Saharan African population using a public health approach
  • The IMPAACT 2017 MOCHA study evaluating switching to LA CAB + RPV in adolescents living with HIV
  • The ACTG A5359 LATITUDE study of LA CAB + RPV in people with adherence challenges to oral ART
  • Updated data from San Francisco’s Ward 86 Clinic using LA CAB + RPV in people without viral suppression at baseline
  • Case series of LA CAB (± RPV) + LEN for select people living with HIV unable to take oral ART and unable to use LA CAB + RPV alone
• Data on HIV and STI prevention, including:
  • The impact of Doxy-PEP guideline implementation on STIs in men who have sex with men and transgender women in San Francisco
  • BIC/FTC/TAF for PEP
  • Offering PrEP following PEP

Presenters:

Samantha Strong, PharmD, BCACP, AAHIVP, CDCES
Clinical Director of Pharmacy
Nevada Health Centers
Las Vegas, Nevada

Nimish Patel, PharmD, PhD, AAHIVP
Professor of Clinical Pharmacy
Skaggs School of Pharmacy & Pharmaceutical Sciences
University of California, San Diego
La Jolla, California

To access all of our new podcast episodes, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

See the full program here:
 https://bit.ly/49x0W6D

In this episode, learn how early and sustained HBV care can be enhanced by expanding the role of primary care providers in HBV management. Learn how to:

• Engage key stakeholders in the provision of HBV care​
• Provide HBV management resources to support PCPs who are doing screening​
• Consider specialty and primary care collaborations that empower PCPs with clear guidance on how to manage patients living with HBV

Presenters:

Su Wang, MD, MPH, FACP
Medical Director
Center for Asian Health and Viral Hepatitis Programs
Cooperman Barnabas Medical Center
RWJBarnabas-Rutgers Medical Group
Associate Member
Health Care Policy and Aging Research
The Rutgers Institute for Health
Senior Advisor
Global Health, Hepatitis B Foundation
Florham Park, New Jersey

Richard R. Andrews, MD, MPH
President, Houston Viral Hepatitis Task Force
Former Co-Chair, National Task Force on Hepatitis B
Board-Certified Family Medicine
Addiction Medicine Physician
Houston, Texas

Ruth Brogden, MPH
Patient Advocate

Amy S. Tang, MD
Former Co-Chair, National Task Force on Hepatitis B
Director of Immigrant Health
North East Medical Services
San Francisco, California

Link to full program: 
https://bit.ly/3TuqFHI

Link to the slides:
https://bit.ly/44hXpHu

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Gregory Huhn, MD, MPHTM, uses a case study to explore the reasons healthcare professionals and people living with HIV may want to further optimize ART in the setting of viral suppression. 

To determine the best outcome for this case study, Dr Huhn discusses the reasons individuals may not be satisfied with daily oral ART and examines data to suggest that, for some individuals with virologic suppression, switching to long-acting ART may address internalized HIV stigma.

Finally, Dr Huhn takes a look at the optimal candidates for switching to a long-acting ART regimen and settings where proviral DNA genotyping may be considered prior to switching.

Presenter:

Gregory Huhn, MD, MPHTM
Interim Chief, Division of Infectious Diseases
Senior Director of HIV Services
Cook County HIV Integrated Programs
Interim Medical Director, The RMR CORE Center
Professor, Division of Infectious Diseases
Rush University Medical Center
Chicago, Illinois

To access all of our new podcast episodes, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

See the full program here.

In this episode, Maria Buti, MD, and her patient discuss opportunities to optimize care for people living with hepatitis B virus (HBV), including: 

• Barriers to HBV screening, including patient- and provider-specific barriers (eg, lack of education, failure to disclose or discuss risk factors, perceived low risk, stigma)
• Applying CDC recommendations for universal HBV screening in adults 
• Strategies to improve HBV transitions of care (eg, improved education, simplify criteria for screening and monitoring, alternative testing sites)
• Importance of testing close contacts for HBV after initial diagnosis and promoting HBV vaccination

Presenter: 

Maria Buti, MD
Professor of Medicine
Senior Consultant
Liver Unit
Hospital Universitario Valle Hebron
Barcelona, Spain

Content based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.

Link to full program:
https://bit.ly/49TuZ8U

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Joseph J. Eron, Jr., MD, and Monica Gandhi, MD, MPH, discuss the key HIV studies from CROI 2024 that are influencing their clinical practice, including:

• New data surrounding long-acting ART, including:
  • The CARES study of LA CAB + RPV in a Sub-Saharan African population using a public health approach
  • The IMPAACT 2017 MOCHA study evaluating switching to LA CAB + RPV in adolescents living with HIV
  • The ACTG A5359 LATITUDE study of LA CAB + RPV in people with adherence challenges to oral ART
  • Updated data from San Francisco’s Ward 86 Clinic using LA CAB + RPV in people without viral suppression at baseline
  • Case series of LA CAB (± RPV) + LEN for select people living with HIV unable to take oral ART and unable to use LA CAB + RPV alone
• Data on comorbidities and coinfections, including:
  • A REPRIEVE proteomic analysis to elucidate mechanistic pathways of statin effects on plaque
  • The ACTG A5371 SLIM LIVER study of semaglutide for MASLD in people living with HIV
  • The impact of Doxy-PEP guideline implementation on STIs in men who have sex with men and transgender women in San Francisco
• Potential novel treatment options on the horizon for people living with HIV, including:
  • Phase II data on LEN + ISL dosed orally once weekly
  • Early data on other oral weekly options
  • Data on bNAbs in combination or with other ART agents

Presenters:

Joseph J. Eron, Jr., MD
Professor of Medicine, School of Medicine
Herman and Louise Smith Distinguished Professor
Chief, Division of Infectious Diseases
Director, Clinical Core, UNC Center for AIDS Research
Adjunct Professor of Epidemiology
Gillings School of Global Public Health
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Monica Gandhi, MD, MPH
Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco
San Francisco, California

Content based on an online CME program supported by independent educational grants from Gilead Sciences; Merck & Co., Inc.; and ViiV Healthcare.

Link to full program: 
https://bit.ly/4awdWJM

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts or Spotify.

In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include:

• Patient subgroups to consider for treatment outside guideline criteria
• Adverse event and cost-effectiveness considerations
• Integration of patient perspectives in wider treatment

Presenters:

Mark S. Sulkowski, MD, FIDSA, FAASLD
Professor of Medicine
Director, Division of Infectious Diseases, Johns Hopkins Bayview Medical Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

Tatyana Kushner, MD, MSCE
Associate Professor
Division of Liver Diseases
Icahn School of Medicine at Mount Sinai
New York, New York

Paul Y. Kwo, MD
Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California

Jacki Chen, PhD
Patient Advocate 

Link to full program: 
https://bit.ly/3TuqFHI

Link to the slides:
https://bit.ly/4a60GM4

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Robert Wong, MD, MS, and a patient discuss opportunities to optimize care for people living with hepatitis B virus (HBV), including:

• Opportunities to improve patient education, including education for expectant mothers with HBV
• Potential cultural considerations that may result in delayed HBV diagnosis and care 
• Stigma reduction with universal HBV screening and vaccination
• Strategies to improve patient education (eg, online resources, advocacy groups, use of layman’s terms and diagrams, repetition)

Presenter: 

Robert Wong, MD, MS 
Clinical Associate Professor 
Division of Gastroenterology and Hepatology
Stanford University School of Medicine
Palo Alto, California

Content based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.

Link to full program: 
https://bit.ly/49TuZ8U

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.